Rosenverse
Digital Medicine Design

Log in or create a free Rosenverse account to watch this video.

Log in Create free account

100s of community videos are available to free members. Conference talks are generally available to Gold members.

Digital Medicine Design

Thursday, September 26, 2019 • Enterprise Community
Share the love for this talk
Digital Medicine Design
Speakers: Daniel J. Rosenberg
Link:

Summary

Can a software only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor’s prescription? The answer to both questions is a responding YES!

In this webinar, Dan walked through several medical product case studies he has consulted on. The first is the WellDoc BlueStar solution for type 2 diabetes patients. BlueStar was the first instance of Digital Medicine invented. BlueStar received both an FDA class 2 certification and a prescription drug code for insurance reimbursement. Legally speaking this 100% software only solution is a medication. In clinical trials it has proven to reduce high-risk type 2 patients A1C levels by more than 1.8 points, outperforming many commonly prescribed medications. The second case study is Bigfoot Biomedical’s artificial pancreas for type 1 diabetics. It has completed its first clinical trial rounds but is not yet in the market. This solution uses an amazing combination of AI, big data and IoT embedded in the human body to automate insulin delivery 24/7. The primary UX resides on the patients’ phone. Interfaces for doctors and insurance companies will complete the end to end system experience including an innovative direct to patients supply chain. In addition to these amazing case studies this webinar described the similarities between digital medicine design and Enterprise UX. You will be surprised to see how much they have in common as well as what else you need to know to enter this cutting-edge UX domain.

Key Insights

  • •

    Digital medicine apps like BlueStar are prescription-only and undergo FDA clearance, making them legally a pharmaceutical class.

  • •

    Only a tiny fraction (about 0.01%) of diabetes apps are FDA-cleared to ensure clinical effectiveness.

  • •

    BlueStar outperforms metformin in lowering A1C by about 2 points through data science and gamification.

  • •

    Bigfoot’s artificial pancreas integrates continuous glucose monitoring with an insulin pump controlled by smartphone, allowing personalized insulin dosing.

  • •

    Medical UX design involves multi-actor systems including patients, caregivers, doctors, payers, pharmacies, and must consider HIPAA regulations.

  • •

    The onboarding and provisioning processes in medical software are far more complex than in enterprise software due to prescriptions, insurance, and regulatory needs.

  • •

    Safety is always the top design priority in digital medicine, followed by privacy and usability.

  • •

    FDA agile process is highly regulated and closer to waterfall with strong documentation and traceability requirements, especially for higher-risk devices.

  • •

    Contextual data like elevation, temperature, and activity levels can personalize insulin dosing algorithms in digital medicine products.

  • •

    User retention issues in medical apps can sometimes mean success, as patients stop using the app after achieving stable health control.

Notable Quotes

"Digital medicine apps are legally considered a pharmaceutical, available by prescription only."

"About 200,000 digital health products exist, but only 1% of 1% have FDA clearance for accuracy."

"BlueStar lowered users' A1C by 2 points, outperforming the most common drug metformin which averages 1.5."

"If the phone dies, Bigfoot’s insulin pump continues working independently, but without new data input."

"You have to keep the injection sites moving because of scar tissue, adding to the body hacking complexity."

"Safety is your number one concern, privacy is your number two, and usability is number three."

"A lot of these companies have founders or investors who are themselves doctors or diabetic patients."

"Design history files must document every design decision for FDA audits—it's far more rigorous than typical usability tests."

"The FDA-approved agile process is more like a controlled waterfall with strict traceability, especially for Class 3 devices."

"If patients stop using the app because they’ve got their health under control, that’s like a dating app success — they got married, not that the app failed."

Ask the Rosenbot
Louis Rosenfeld
The Bigger Picture: A Panel Discussion
2019 • DesignOps Summit 2019
Gold
Sam Proulx
Mobile Accessibility: Why Moving Accessibility Beyond the Desktop is Critical in a Mobile-first World
2022 • Civic Design 2022
Gold
Lisanne Norman
Why I Left Research
2023 • Advancing Research 2023
Gold
Vitorio Miliano
Don’t call it AI: Turn words into numbers with quantitative ethnography
2026 • Advancing Research 2026
Gold
Erika Flowers
Introduction to MURAL for UX
2021 • Design at Scale 2021
Gold
Brenna Fallon
Learning Over Outcomes
2019 • DesignOps Summit 2019
Gold
Ryan Matthew
Bridging Design and Code: AI-Powered Design System Integration
2025 • Rosenfeld Community
Jay Bustamante
Navigating the Ethical Frontier: DesignOps Strategies for Responsible AI Innovation
2023 • DesignOps Summit 2023
Gold
The AI + Design wave has arrived: Making sense of the 2026 AI + Design Report
2026 • Rosenfeld Community
Tess Dixon
C'mon Get Happy
2021 • DesignOps Summit 2021
Gold
Jackie Ajoux
Leveling-Up: A Single-Player’s Guide to the DesignOps Team-of-One
2024 • DesignOps Summit 2020
Gold
Nick Fine
How UX researchers can partner with (and not be replaced by) AI [Advancing Research Community Workshop Series]
2023 • Advancing Research Community
Kate Koch
Flex Your Super Powers: When a Design Ops Team Scales to Power CX
2021 • DesignOps Summit 2021
Gold
Joanna Vodopivec
One Research Team for All - Influence Without Authority
2022 • Advancing Research 2022
Gold
Megan Blocker
Panel: Excellence in Impact
2024 • Advancing Research 2024
Gold
Jennifer Kanyamibwa
Creating the Blueprint: Growing and Building Design Teams
2018 • DesignOps Summit 2018
Gold

More Videos

Dr. Karl Jeffries

"If you value innovation and design, then you're investing in creativity."

Dr. Karl Jeffries

The Science of Creativity for DesignOps

January 8, 2024

Amy Marquez

"Investment is attention: If the business funds you, it means they believe in what you do."

Amy Marquez

INVEST: Discussion

June 15, 2018

Steve Portigal

"Both tribes really believe in doing awesome for customers, that’s our common ground."

Steve Portigal Chris Chapo Kelly Goto Christian Rohrer

Discussion

May 13, 2015

Alicia Mooty

"Involving designers early in the process is crucial to avoid the 'fast-food' model where they feel like order takers."

Alicia Mooty

Design Staffing Models

September 30, 2021

Ana Maria Montero Barrantes

"Research in science fiction helps make research real and creative all the time."

Ana Maria Montero Barrantes Aditi Dhar Michelle Kaplan Nate Osborne Matt Laurence

The Authentic UX Talent Show

January 8, 2024

Lada Gorlenko

"Operations tends to be something companies only think about when they are scaling rapidly, but investing early is essential."

Lada Gorlenko Sharbani Dhar Sébastien Malo Rob Mitzel Ivana Ng Michal Anne Rogondino

Theme 1: Discussion

January 8, 2024

Sofia Quintero

"We think about research as the magnetic field that attracts every part of the business into alignment around the customer."

Sofia Quintero

The Product Philosophy Behind EnjoyHQ

March 10, 2021

Laura Klein

"Lawyers, though nervous, can become some of the most reasonable people you deal with if you explain risks clearly."

Laura Klein

Unique challenges of innovation in enterprises

April 23, 2020

Andrew Michael

"Without Jim, what we're going to see today would have been a lot worse."

Andrew Michael

Building a Product Insights Team

March 10, 2022

Latest Books All books